Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-20-012287

VP Research & Development sold 567 shares at $17.81 ($10,098)

  • VP Research & Development acquired 2,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Scopelianos Angelo VP Research & Development 2020-12-27 Grant or award +2,300 6,096 D
Scopelianos Angelo VP Research & Development 2020-12-29 Sale −567 $17.81 $10,098 5,529 D
Open-market sales · 567 sh · avg $17.81 · $10,098
Loading xslF345X03/edgar.xml…